Tim Opler

Verified account

@TimOpler

Joined November 2021

816 Following

1.9K Followers

4 Posts

TimOpler retweeted

7 months ago

Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB

daphnezohar's tweet photo. Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB https://t.co/udCuhIcaIi

daphnezohar's tweet photo. Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB https://t.co/udCuhIcaIi

daphnezohar's tweet photo. Biotech M&A on track to have 2nd most active year in history w/ more early stage deals. Nice summary of which funds have benefited from recent M&A from Stifel @TimOpler $XBI $IBB https://t.co/udCuhIcaIi

8

230

45

132

33K

TimOpler retweeted

about 1 year ago

Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

daphnezohar's tweet photo. Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

daphnezohar's tweet photo. Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

daphnezohar's tweet photo. Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

daphnezohar's tweet photo. Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

29

378

76

227

105K

almost 2 years ago

@damienics @bradloncar https://t.co/9PzDKJc9J8

1

13

1

12

684

almost 4 years ago

@BertrandBio @BiotechCH @daphnezohar @JSchimmer_E @TheDawnBell @SamFazeli8 @robperez32 @LifeSciVC @mpreminger @eperlste @Seals310 https://t.co/a8G9z4xiUH

2

14

3

5

3K

Who to follow

Goose Data (wa/wa)

Biotech visionary. Looking for best drugs with goose data. Retweets mean honking endorsement.

Verified account

your dose of biotech & healthcare commentary • founder @sleuthinsights • building software for the bioeconomy

John Maraganore 🇺🇸🇬🇷🇺🇦

Verified account

Founding CEO of @Alnylam. Pioneered RNAi therapeutics as a whole new class of medicines for patients. Now bioentrepreneur-at-large. Opinions are my own.

Last Seen Users on Sotwe

Trends for you

Most Popular Users